---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-415555"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2026-10-06T20:06:55+00:00"
generated_at: "2026-10-12T16:20:57.187070+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Inovio adds Delaware exclusive-forum bylaw covering derivative and fiduciary-duty suits

## Summary
- Board approved the Bylaws Amendment on October 6, 2026, effective immediately; CFO Peter Kies signed the report.
- New Article 12 designates the Delaware Court of Chancery as exclusive forum for derivative actions and claims of breach of fiduciary duty by directors, officers or stockholders.
- The U.S. federal district courts are named the exclusive forum for any complaint arising under the Securities Act of 1933.
- Full text of the amendment is filed as Exhibit 3.1 to the Form 8-K; no financial terms or dollar amounts disclosed.
- No change to the Company's certificate of incorporation, fiscal year, or share count was disclosed.

## SEC filing metadata
- accession: 0001193125-26-415555
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2026-10-06T20:06:55+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312526415555/0001193125-26-415555-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312526415555/d127604d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-415555
- JSON: https://secwatch.observer/filing/0001193125-26-415555.json
- Plain text: https://secwatch.observer/filing/0001193125-26-415555.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.